hh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Antipsychotic medication in relation to national directives in people with dementia in Sweden
Halmstad University, School of Health and Welfare, Centre of Research on Welfare, Health and Sport (CVHI), Health and Nursing. Lund University, Lund, Sweden.ORCID iD: 0000-0002-6624-9963
Lund University, Lund, Sweden.
Lund University, Lund, Sweden.
Blekinge Institute of Technology, Karlskrona, Sweden & Blekinge Centre of Competence, Karlskrona, Sweden.
2017 (English)In: IAGG 2017 Abstract Book, Washington, DC: The Gerontological Society of America , 2017, p. 349-350Conference paper, Poster (with or without abstract) (Refereed)
Abstract [en]

The aim of this study was to explore trends in treatment with antipsychotic medication in Swedish dementia care as reported in the most recent empirical studies on the topic, and to relate these trends to directives and recommendations from national authorities.

The study included two scoping review studies and two empirical studies. The scoping studies reviewed published data in electronic databases as well as Swedish recommendations and directives in the field.

During the past decade, recommendations have been developed regarding antipsychotic medication in Sweden. These recommendations were generic at first, but have become increasingly specific and restrictive with time. The scoping review showed that treatment with antipsychotic drugs varied between 6% and 38%, and was higher in younger older persons and those with moderate cognitive impairment and living in nursing homes for people with dementia. A trend towards a decrease in antipsychotic use has been seen over the last 15 years. The empirical studies showed that the medication with antipsychotics decreased from 23.4% in 2001 to 11.5% in 2007, for older people in general as well as for older people with dementia. Among older people with dementia, 10% were utilizing antipsychotic medication, with no difference between those cared for at home and those in nursing homes.

Directives from Swedish national authorities seem to have had an impact on antipsychotic medication for people with dementia. Treatment with antipsychotic medication has decreased, while other psychotropic medication has increased. National directives may possibly be even more effective, if applied in combination with systematic follow-ups.

Place, publisher, year, edition, pages
Washington, DC: The Gerontological Society of America , 2017. p. 349-350
Series
Innovation in aging, E-ISSN 2399-5300 ; Suppl. 1
Keyword [en]
Dementia, Antipsychotic medication, Drug utilization, Directive
National Category
Nursing
Identifiers
URN: urn:nbn:se:hh:diva-36007OAI: oai:DiVA.org:hh-36007DiVA: diva2:1169678
Conference
21st IAGG World Congress of Gerontology and Geriatrics, in San Francisco, USA, July 23-27, 2017
Available from: 2017-12-29 Created: 2017-12-29 Last updated: 2018-01-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Abstract book

Authority records BETA

Karlsson, Staffan

Search in DiVA

By author/editor
Karlsson, Staffan
By organisation
Health and Nursing
Nursing

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 10 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf